P83916
Gene name |
CBX1 (CBX) |
Protein name |
Chromobox protein homolog 1 |
Names |
HP1Hsbeta, Heterochromatin protein 1 homolog beta, HP1 beta, Heterochromatin protein p25, M31, Modifier 1 protein, p25beta |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:10951 |
EC number |
|
Protein Class |
|

Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

7 structures for P83916
65 variants for P83916
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs1273061679 CA400066333 |
2 | G>V | No |
ClinGen gnomAD |
|
CA400066228 rs1194826901 |
5 | Q>K | No |
ClinGen TOPMed |
|
CA291310336 rs1016000584 |
5 | Q>L | No |
ClinGen Ensembl |
|
CA8630937 rs762873265 |
7 | K>N | No |
ClinGen ExAC gnomAD |
|
rs1290187165 CA400066099 |
9 | K>R | No |
ClinGen TOPMed |
|
TCGA novel | 9 | K>W | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs775410359 CA8630936 |
10 | V>M | No |
ClinGen ExAC TOPMed |
|
rs1598304509 CA400066017 |
11 | E>D | No |
ClinGen Ensembl |
|
rs1218763751 CA400065991 |
13 | V>M | No |
ClinGen TOPMed |
|
CA400065917 rs1294002108 |
17 | E>Q | No |
ClinGen gnomAD |
|
CA291310314 rs1026601887 |
19 | E>K | No |
ClinGen Ensembl |
|
rs745952905 CA8630934 |
28 | D>N | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
CA400065725 rs1391871688 |
29 | R>H | No |
ClinGen gnomAD |
|
rs902055553 CA291310306 |
30 | R>Q | No |
ClinGen gnomAD |
|
CA400065665 rs1474976282 |
37 | E>D | No |
ClinGen TOPMed |
|
TCGA novel | 42 | W>* | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
TCGA novel | 44 | G>* | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA400065330 rs1598304131 |
57 | N>H | No |
ClinGen Ensembl |
|
TCGA novel | 60 | C>Y | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA400065182 rs1253995769 |
65 | A>G | No |
ClinGen gnomAD |
|
TCGA novel | 65 | A>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
TCGA novel | 66 | E>Q | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA291309879 rs112724635 |
68 | L>P | No |
ClinGen Ensembl |
|
CA8630907 rs779462460 |
70 | S>L | No |
ClinGen ExAC gnomAD |
|
rs1463708838 CA400065035 |
73 | T>A | No |
ClinGen gnomAD |
|
CA400064920 rs1482698962 |
77 | T>R | No |
ClinGen TOPMed gnomAD |
|
rs755420416 CA8630906 |
78 | D>G | No |
ClinGen ExAC gnomAD |
|
CA8630904 rs780561799 |
79 | K>I | No |
ClinGen ExAC gnomAD |
|
CA8630902 rs751114803 |
82 | G>R | No |
ClinGen ExAC gnomAD |
|
TCGA novel | 83 | G>C | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs763754395 CA8630901 |
85 | R>C | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
CA400064652 rs1390319526 |
85 | R>H | No |
ClinGen gnomAD |
|
CA8630900 rs140922985 |
86 | K>R | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs140922985 CA291309831 |
86 | K>T | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA8630899 rs752455527 |
90 | D>N | No |
ClinGen ExAC gnomAD |
|
rs1567763892 CA400064424 |
94 | K>T | No |
ClinGen Ensembl |
|
CA8630898 rs765062326 |
95 | G>R | No |
ClinGen ExAC gnomAD |
|
CA400064384 rs1288110001 |
97 | E>V | No |
ClinGen TOPMed |
|
rs1361500904 CA400064359 |
98 | S>N | No |
ClinGen TOPMed |
|
rs776637506 CA8630897 |
98 | S>R | No |
ClinGen ExAC gnomAD |
|
rs1188311363 CA400064295 |
100 | P>L | No |
ClinGen gnomAD |
|
COSM1236233 CA400064200 rs1441966641 |
103 | K>N | autonomic_ganglia [Cosmic] | No |
ClinGen cosmic curated gnomAD |
CA400064202 rs1216626997 |
103 | K>R | No |
ClinGen gnomAD |
|
CA400063347 rs1382220039 |
115 | R>Q | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
rs1414793625 CA400063313 |
116 | G>A | No |
ClinGen gnomAD |
|
rs1356693722 CA400063204 |
119 | P>L | No |
ClinGen TOPMed gnomAD |
|
rs1408505956 CA400063161 |
120 | E>D | No |
ClinGen TOPMed gnomAD |
|
rs1405002624 CA400062588 |
136 | M>I | No |
ClinGen gnomAD |
|
rs1298438311 CA400062605 |
136 | M>L | No |
ClinGen TOPMed gnomAD |
|
CA8630851 rs756109344 |
139 | K>R | No |
ClinGen ExAC TOPMed gnomAD |
|
CA400060428 rs1598301770 |
140 | N>T | No |
ClinGen Ensembl |
|
rs1598301756 CA400060309 |
145 | D>A | No |
ClinGen Ensembl |
|
CA400060267 rs1598301744 |
147 | V>A | No |
ClinGen Ensembl |
|
CA400060275 rs1400058693 |
147 | V>F | No |
ClinGen TOPMed |
|
rs1598301734 CA400060137 |
153 | N>S | No |
ClinGen Ensembl |
|
CA400060110 rs1337074942 |
154 | V>F | No |
ClinGen TOPMed |
|
TCGA novel | 154 | V>I | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA8630848 rs761996259 |
164 | Y>C | No |
ClinGen ExAC gnomAD |
|
CA8630845 rs373324667 |
175 | S>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA8630843 rs765576475 |
177 | D>E | No |
ClinGen ExAC gnomAD |
|
TCGA novel | 178 | D>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs202060104 CA291306614 |
181 | K>E | No |
ClinGen 1000Genomes |
|
rs111515382 CA291306609 |
181 | K>T | No |
ClinGen Ensembl |
|
TCGA novel | 182 | D>M | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs202111986 CA291306604 |
183 | D>G | No |
ClinGen 1000Genomes |
No associated diseases with P83916
8 regional properties for P83916
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Chromo/chromo shadow domain | 20 - 79 | IPR000953-1 |
domain | Chromo/chromo shadow domain | 116 - 175 | IPR000953-2 |
domain | Chromo shadow domain | 111 - 173 | IPR008251 |
domain | Chromo domain subgroup | 18 - 26 | IPR017984-1 |
domain | Chromo domain subgroup | 31 - 45 | IPR017984-2 |
domain | Chromo domain subgroup | 46 - 58 | IPR017984-3 |
conserved_site | Chromo domain, conserved site | 38 - 58 | IPR023779 |
domain | Chromo domain | 21 - 69 | IPR023780 |
12 GO annotations of cellular component
Name | Definition |
---|---|
chromatin | The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. |
chromocenter | A region in which centric, heterochromatic portions from more than one chromosomes form a compact structure. |
chromosome, centromeric region | The region of a chromosome that includes the centromeric DNA and associated proteins. In monocentric chromosomes, this region corresponds to a single area of the chromosome, whereas in holocentric chromosomes, it is evenly distributed along the chromosome. |
chromosome, telomeric region | The end of a linear chromosome, required for the integrity and maintenance of the end. A chromosome telomere usually includes a region of telomerase-encoded repeats the length of which rarely exceeds 20 bp each and that permits the formation of a telomeric loop (T-loop). The telomeric repeat region is usually preceded by a sub-telomeric region that is gene-poor but rich in repetitive elements. Some telomeres only consist of the latter part (for eg. D. melanogaster telomeres). |
female pronucleus | The pronucleus originating from the ovum that is being fertilized. |
heterochromatin | A compact and highly condensed form of chromatin that is refractory to transcription. |
male pronucleus | The pronucleus originating from the spermatozoa that was involved in fertilization. |
nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
pericentric heterochromatin | Heterochromatin that is located adjacent to the CENP-A rich centromere 'central core' and characterized by methylated H3 histone at lysine 9 (H3K9me2/H3K9me3). |
site of DNA damage | A region of a chromosome at which DNA damage has occurred. DNA damage signaling and repair proteins accumulate at the lesion to respond to the damage and repair the DNA to form a continuous DNA helix. |
spindle | The array of microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during mitosis or meiosis and serves to move the duplicated chromosomes apart. |
7 GO annotations of molecular function
Name | Definition |
---|---|
chromatin binding | Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase. |
DNA binding | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
enzyme binding | Binding to an enzyme, a protein with catalytic activity. |
histone methyltransferase binding | Binding to a histone methyltransferase enzyme. |
identical protein binding | Binding to an identical protein or proteins. |
methylated histone binding | Binding to a histone in which a residue has been modified by methylation. |
molecular adaptor activity | The binding activity of a molecule that brings together two or more molecules through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way. |
3 GO annotations of biological process
Name | Definition |
---|---|
cellular response to DNA damage stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism. |
chromatin organization | The assembly or remodeling of chromatin composed of DNA complexed with histones, other associated proteins, and sometimes RNA. |
negative regulation of transcription by RNA polymerase II | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. |
7 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q99549 | MPHOSPH8 | M-phase phosphoprotein 8 | Homo sapiens (Human) | PR |
Q9Y232 | CDYL | Chromodomain Y-like protein | Homo sapiens (Human) | PR |
Q8N8U2 | CDYL2 | Chromodomain Y-like protein 2 | Homo sapiens (Human) | PR |
Q9WTK2 | Cdyl | Chromodomain Y-like protein | Mus musculus (Mouse) | PR |
Q9D5D8 | Cdyl2 | Chromodomain Y-like protein 2 | Mus musculus (Mouse) | PR |
P83917 | Cbx1 | Chromobox protein homolog 1 | Mus musculus (Mouse) | PR |
Q6AYK9 | Cdyl | Chromodomain Y-like protein | Rattus norvegicus (Rat) | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MGKKQNKKKV | EEVLEEEEEE | YVVEKVLDRR | VVKGKVEYLL | KWKGFSDEDN | TWEPEENLDC |
70 | 80 | 90 | 100 | 110 | 120 |
PDLIAEFLQS | QKTAHETDKS | EGGKRKADSD | SEDKGEESKP | KKKKEESEKP | RGFARGLEPE |
130 | 140 | 150 | 160 | 170 | 180 |
RIIGATDSSG | ELMFLMKWKN | SDEADLVPAK | EANVKCPQVV | ISFYEERLTW | HSYPSEDDDK |
KDDKN |